View in EDS

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.

Saved in:
Bibliographic Details
Title: Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
Authors: Motzer, R.J.1 (AUTHOR) motzerr@mskcc.org, Escudier, B.2 (AUTHOR), Burotto, M.3 (AUTHOR), Powles, T.4 (AUTHOR), Apolo, A.B.5 (AUTHOR), Bourlon, M.T.6 (AUTHOR), Shah, A.Y.7 (AUTHOR), Porta, C.8 (AUTHOR), Suárez, C.9 (AUTHOR), Barrios, C.H.10 (AUTHOR), Richardet, M.11 (AUTHOR), Gurney, H.12 (AUTHOR), Kessler, E.R.13 (AUTHOR), Tomita, Y.14,15 (AUTHOR), Bedke, J.16 (AUTHOR), Scheffold, C.17 (AUTHOR), Askelson, M.18 (AUTHOR), Panzica, J.19 (AUTHOR), Zhang, J.20 (AUTHOR), van Kooten Losio, M.1,21 (AUTHOR)
Source: Annals of Oncology. Jan2026, Vol. 37 Issue 1, p33-43. 11p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 190357527
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Motzer%2C+R%2EJ%2E%22">Motzer, R.J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> motzerr@mskcc.org</i><br /><searchLink fieldCode="AR" term="%22Escudier%2C+B%2E%22">Escudier, B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burotto%2C+M%2E%22">Burotto, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powles%2C+T%2E%22">Powles, T.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Apolo%2C+A%2EB%2E%22">Apolo, A.B.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bourlon%2C+M%2ET%2E%22">Bourlon, M.T.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shah%2C+A%2EY%2E%22">Shah, A.Y.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Porta%2C+C%2E%22">Porta, C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Suárez%2C+C%2E%22">Suárez, C.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barrios%2C+C%2EH%2E%22">Barrios, C.H.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Richardet%2C+M%2E%22">Richardet, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gurney%2C+H%2E%22">Gurney, H.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kessler%2C+E%2ER%2E%22">Kessler, E.R.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tomita%2C+Y%2E%22">Tomita, Y.</searchLink><relatesTo>14,15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bedke%2C+J%2E%22">Bedke, J.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scheffold%2C+C%2E%22">Scheffold, C.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Askelson%2C+M%2E%22">Askelson, M.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Panzica%2C+J%2E%22">Panzica, J.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+J%2E%22">Zhang, J.</searchLink><relatesTo>20</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Kooten+Losio%2C+M%2E%22">van Kooten Losio, M.</searchLink><relatesTo>1,21</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Jan2026, Vol. 37 Issue 1, p33-43. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190357527
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.09.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 33
    Titles:
      – TitleFull: Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Motzer, R.J.
      – PersonEntity:
          Name:
            NameFull: Escudier, B.
      – PersonEntity:
          Name:
            NameFull: Burotto, M.
      – PersonEntity:
          Name:
            NameFull: Powles, T.
      – PersonEntity:
          Name:
            NameFull: Apolo, A.B.
      – PersonEntity:
          Name:
            NameFull: Bourlon, M.T.
      – PersonEntity:
          Name:
            NameFull: Shah, A.Y.
      – PersonEntity:
          Name:
            NameFull: Porta, C.
      – PersonEntity:
          Name:
            NameFull: Suárez, C.
      – PersonEntity:
          Name:
            NameFull: Barrios, C.H.
      – PersonEntity:
          Name:
            NameFull: Richardet, M.
      – PersonEntity:
          Name:
            NameFull: Gurney, H.
      – PersonEntity:
          Name:
            NameFull: Kessler, E.R.
      – PersonEntity:
          Name:
            NameFull: Tomita, Y.
      – PersonEntity:
          Name:
            NameFull: Bedke, J.
      – PersonEntity:
          Name:
            NameFull: Scheffold, C.
      – PersonEntity:
          Name:
            NameFull: Askelson, M.
      – PersonEntity:
          Name:
            NameFull: Panzica, J.
      – PersonEntity:
          Name:
            NameFull: Zhang, J.
      – PersonEntity:
          Name:
            NameFull: van Kooten Losio, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1